| ²é¿´: 317 | »Ø¸´: 0 | |||
·ÛµåÀ¶Ä¾³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
¡¾ÇóÖú/½»Á÷¡¿ÎÄÏ×ÇóÖú ÏÈллÀ²
|
|
µÚһƪ£ºCirculation. 2003;108:2697.) 2003 American Heart Association, Inc ÌâÄ¿Anticoagulants (Thrombin Inhibitors) and Aspirin Synergize With P2Y12 Receptor Antagonism in Thrombosis ×÷ÕߣºPatrick Andr¨¦, PhD; Thomas LaRocca, BA; Suzanne M. Delaney, PhD µÚ¶þƪ£ºCirculation. 2003;107:1123.) 2003 American Heart Association, Inc. ÌâÄ¿£ºInhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation ×÷ÕߣºLisa Nannizzi-Alaimo, BSc; Veronica L. Alves, BSc; David R. Phillips, PhD |
» ²ÂÄãϲ»¶
²ÄÁÏÀà284µ÷¼Á
ÒѾÓÐ46È˻ظ´
±¾ÈËÅ®º¢
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
¹ã¶«Ê¡ 085601 329·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
277 ÊýÒ»104£¬Ñ§Ë¶£¬Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
µ÷¼Á
ÒѾÓÐ13È˻ظ´
080500Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
272·Ö²ÄÁÏ×ÓÇóµ÷¼Á
ÒѾÓÐ34È˻ظ´













»Ø¸´´ËÂ¥